Literature DB >> 22423035

Adenosine signaling: good or bad in erectile function?

Jiaming Wen1, Yang Xia.   

Abstract

The erectile status of penile tissue is governed largely by the tone of cavernosal smooth muscle cells, which is determined by the balance of vascular relaxants and constrictors. Vascular relaxants play a key role in regulating the tone of cavernosal smooth muscle and thus the initiation and maintenance of penile erection. Early studies drew attention to the potential role of adenosine signaling in this process. However, the serendipitous discovery of the effect of sildenafil on erectile physiology drew more attention toward nitric oxide (NO) as a vasodilator in the process of penile erection, and a recently discovered, unexpected erectile phenotype of adenosine deaminase-deficient mice reemphasizes the importance of adenosine as a key regulatory of erectile status. Adenosine, like NO, is a potent and short-lived vasorelaxant that functions via cyclic nucleotide second messenger signaling to promote smooth muscle relaxation. Recent studies reviewed here show that adenosine functions to relax the corpus cavernosum and promote penile erection. Excess adenosine in penile tissue contributes to the disorder called priapism, and impaired adenosine signaling is associated with erectile dysfunction. More recent research summarized in this review reveals that adenosine functions as a key endogenous vasodilator in the initiation and maintenance of normal penile erection. This new insight highlights adenosine signaling pathways operating in penile tissue as significant therapeutic targets for the treatment of erectile disorders.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22423035     DOI: 10.1161/ATVBAHA.111.226803

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  10 in total

1.  Nitrergic Mechanisms for Management of Recurrent Priapism.

Authors:  Uzoma A Anele; Arthur L Burnett
Journal:  Sex Med Rev       Date:  2015-06-04

Review 2.  Beneficial and detrimental role of adenosine signaling in diseases and therapy.

Authors:  Hong Liu; Yang Xia
Journal:  J Appl Physiol (1985)       Date:  2015-08-27

Review 3.  Purinergic signalling in the reproductive system in health and disease.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2013-11-23       Impact factor: 3.765

Review 4.  Purinergic Signalling: Therapeutic Developments.

Authors:  Geoffrey Burnstock
Journal:  Front Pharmacol       Date:  2017-09-25       Impact factor: 5.810

5.  Role of Adenosine Receptor(s) in the Control of Vascular Tone in the Mouse Pudendal Artery.

Authors:  Hicham Labazi; Stephen L Tilley; Catherine Ledent; S Jamal Mustafa
Journal:  J Pharmacol Exp Ther       Date:  2015-12-30       Impact factor: 4.030

6.  Functional changes in vascular reactivity to adenosine receptor activation in type I diabetic mice.

Authors:  Hicham Labazi; Bunyen Teng; S Jamal Mustafa
Journal:  Eur J Pharmacol       Date:  2017-12-18       Impact factor: 4.432

7.  Downregulation of metabolic activity increases cell survival under hypoxic conditions: potential applications for tissue engineering.

Authors:  Jaehyun Kim; Karl-Erik Andersson; John D Jackson; Sang Jin Lee; Anthony Atala; James J Yoo
Journal:  Tissue Eng Part A       Date:  2014-07-02       Impact factor: 3.845

8.  Guanosine, a guanine-based nucleoside relaxed isolated corpus cavernosum from mice through cGMP accumulation.

Authors:  Aline de Souza Nicoletti; Gabriela Reolon Passos; Gabriela Maria Bertollotto; Caroline Honaiser Lescano; Mariana Gonçalves de Oliveira; Edson Antunes; Fabiola Zakia Mónica
Journal:  Purinergic Signal       Date:  2020-05-27       Impact factor: 3.765

Review 9.  Adenosine: a partially discovered medicinal agent.

Authors:  Rohit Batra; Vinay Jain; Pankaj Sharma
Journal:  Futur J Pharm Sci       Date:  2021-10-21

Review 10.  The Role of Adenosine A2A Receptor, CYP450s, and PPARs in the Regulation of Vascular Tone.

Authors:  Maan T Khayat; Mohammed A Nayeem
Journal:  Biomed Res Int       Date:  2017-08-13       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.